Reply to H.J.A. Adams et al and E. Laffon et al

Affiliations

¹ Michel Meignan and Anne Ségolène Cottereau, Hôpital Henri Mondor, University Paris-Est Créteil, Créteil, France; Annibale Versari, Santa Maria Nuova Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy; Loïc Chartier, Centre Hospitalier Lyon Sud, Pierre Bénite, France; Jehan Dupuis, Hôpital Henri Mondor, University Paris-Est Créteil, Créteil, France; Sami Boussetta, Centre Hospitalier Lyon Sud, Pierre Bénite, France; Ilaria Grassi, Santa Maria Nuova Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy; René-Olivier Casasnovas, Hôpital le Bocage, Centre Hospitalier Universitaire-Dijon, Dijon, France; Corinne Haioun, Hôpital Henri Mondor, University Paris-Est Créteil, Créteil, France; Hervé Tilly, Université de Rouen, Rouen; Vittoria Tarantino, University of Modena and Reggio Emilia, Modena, Italy; Julien Dubreuil, Centre Hospitalier Lyon Sud, Pierre Bénite, France; Massimo Federico, University of Modena and Reggio Emilia, Modena, Italy; Gilles Salles, Université Claude Bernard Lyon 1, Pierre Bénite, France; Stefano Luminari, University of Modena and Reggio Emilia, Reggio Emilia, Italy; and Judith Trotman, Concord Hospital, University of Sydney, Concord, New South Wales, Australia.

Comment

Michel Meignan et al. J Clin Oncol. 2017.

. 2017 Mar 10;35(8):920-923.

doi: 10.1200/JCO.2016.71.0459. Epub 2016 Dec 28.

¹ Michel Meignan and Anne Ségolène Cottereau, Hôpital Henri Mondor, University Paris-Est Créteil, Créteil, France; Annibale Versari, Santa Maria Nuova Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy; Loïc Chartier, Centre Hospitalier Lyon Sud, Pierre Bénite, France; Jehan Dupuis, Hôpital Henri Mondor, University Paris-Est Créteil, Créteil, France; Sami Boussetta, Centre Hospitalier Lyon Sud, Pierre Bénite, France; Ilaria Grassi, Santa Maria Nuova Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy; René-Olivier Casasnovas, Hôpital le Bocage, Centre Hospitalier Universitaire-Dijon, Dijon, France; Corinne Haioun, Hôpital Henri Mondor, University Paris-Est Créteil, Créteil, France; Hervé Tilly, Université de Rouen, Rouen; Vittoria Tarantino, University of Modena and Reggio Emilia, Modena, Italy; Julien Dubreuil, Centre Hospitalier Lyon Sud, Pierre Bénite, France; Massimo Federico, University of Modena and Reggio Emilia, Modena, Italy; Gilles Salles, Université Claude Bernard Lyon 1, Pierre Bénite, France; Stefano Luminari, University of Modena and Reggio Emilia, Reggio Emilia, Italy; and Judith Trotman, Concord Hospital, University of Sydney, Concord, New South Wales, Australia.

No abstract available

Comment on

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.
Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, Grassi I, Casasnovas RO, Haioun C, Tilly H, Tarantino V, Dubreuil J, Federico M, Salles G, Luminari S, Trotman J. Meignan M, et al. J Clin Oncol. 2016 Oct 20;34(30):3618-3626. doi: 10.1200/JCO.2016.66.9440. Epub 2016 Sep 30. J Clin Oncol. 2016. PMID: 27551111
Overestimated Value of Baseline Total Metabolic Tumor Volume at ¹⁸F-Labeled Fluorodeoxyglucose Positron Emission Tomography in Follicular Lymphoma.
Adams HJ, Kwee TC. Adams HJ, et al. J Clin Oncol. 2017 Mar 10;35(8):918-919. doi: 10.1200/JCO.2016.70.4890. Epub 2016 Dec 28. J Clin Oncol. 2017. PMID: 28029311 No abstract available.
On the Cutoff of Baseline Total Metabolic Tumor Volume in High-Tumor-Burden Follicular Lymphoma.
Laffon E, Marthan R. Laffon E, et al. J Clin Oncol. 2017 Mar 10;35(8):919-920. doi: 10.1200/JCO.2016.70.6150. Epub 2016 Dec 28. J Clin Oncol. 2017. PMID: 28029314 No abstract available.